相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interstitial Lung Disease in Patients with Rheumatoid Arthritis: Spontaneous and Drug Induced
Robert W. Hallowell et al.
DRUGS (2014)
Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
Takao Koike et al.
Modern Rheumatology (2014)
Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: A systematic literature review
Camille Roubille et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis
Tamao Nakashita et al.
BMJ OPEN (2014)
Methotrexate and Lung Disease in Rheumatoid Arthritis
Richard Conway et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Methotrexate-induced pulmonary toxicity
Baruch D. Jakubovic et al.
CANADIAN RESPIRATORY JOURNAL (2013)
Exacerbation of combined pulmonary fibrosis and emphysema syndrome during tocilizumab therapy for rheumatoid arthritis
Daniel Wendling et al.
JOINT BONE SPINE (2013)
Association between anti-TNF-α therapy and interstitial lung disease
Lisa J. Herrinton et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Different risk factors between interstitial lung disease and airway disease in rheumatoid arthritis
Shunsuke Mori et al.
RESPIRATORY MEDICINE (2012)
Interstitial lung disease following certolizumab pegol
Fiona Pearce et al.
RHEUMATOLOGY (2012)
A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab
Shin-ya Kawashiri et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Biological treatments and connective tissue disease associated interstitial lung disease
Stylianos T. Panopoulos et al.
CURRENT OPINION IN PULMONARY MEDICINE (2011)
Non-infectious pulmonary complications of newer biological agents for rheumatic diseases-a systematic literature review
Andreas V. Hadjinicolaou et al.
RHEUMATOLOGY (2011)
Interstitial lung disease in rheumatoid arthritis: response to IL-6R blockade
M. Mohr et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2011)
Interstitial Lung Disease Induced or Exacerbated by TNF-Targeted Therapies: Analysis of 122 Cases
Roberto Perez-Alvarez et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2011)
Rheumatoid Arthritis-Associated Interstitial Lung Disease: Diagnostic Dilemma
Mark J. Hamblin et al.
PULMONARY MEDICINE (2011)
Interstitial Lung Disease in Rheumatoid Arthritis in the Era of Biologics
A. Picchianti Diamanti et al.
PULMONARY MEDICINE (2011)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register
W. G. Dixon et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Incidence and Mortality of Interstitial Lung Disease in Rheumatoid Arthritis
Tim Bongartz et al.
ARTHRITIS AND RHEUMATISM (2010)
Interstitial lung disease and anti-INF-alpha therapy in rheumatoid arthritis: Two different patterns?
A. Schuller et al.
REVUE DES MALADIES RESPIRATOIRES (2010)
Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort
Gouri Koduri et al.
RHEUMATOLOGY (2010)
TNF-α induces TGF-β1expression in lung fibroblasts at the transcriptional levelviaAP-1 activation
Deborah E. Sullivan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis
Tetsuji Sawada et al.
RHEUMATOLOGY (2009)
Progressive preclinical interstitial lung disease in rheumatoid arthritis
Bernadette R. Gochuico et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Organizing pneumonia after rituximab therapy: Two cases
Martin Soubrier et al.
JOINT BONE SPINE (2008)
Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish thoracic society
A. U. Wells et al.
THORAX (2008)
BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists
K. Chakravarty et al.
RHEUMATOLOGY (2008)
Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis
T. Takeuchi et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Rituximab-induced interstitial lung disease
Stephanie A. Wagner et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Pulmonary involvement in rheumatoid arthritis
A Bilgici et al.
RHEUMATOLOGY INTERNATIONAL (2005)
Cardiovascular Death in Rheumatoid Arthritis A Population-Based Study
Hilal Maradit-Kremers et al.
ARTHRITIS AND RHEUMATISM (2005)
Infliximab treatment in a patient with rheumatoid arthritis and pulmonary fibrosis
E Bargagli et al.
EUROPEAN RESPIRATORY JOURNAL (2004)
Repression of bleomycin-induced pneumopathy by TNF
M Kuroki et al.
JOURNAL OF IMMUNOLOGY (2003)
Investigation of the chronic pulmonary effects of low-dose oral methotrexate in patients with rheumatoid arthritis: a prospective study incorporating HRCT scanning and pulmonary function tests
JK Dawson et al.
RHEUMATOLOGY (2002)
Spectrum of CD4 to CD8 T-cell ratios in lymphocytic alveolitis associated with methotrexate-induced pneumonitis
C Fuhrman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Health-related quality of life in COPD:: why both disease-specific and generic measures should be used
CP Engström et al.
EUROPEAN RESPIRATORY JOURNAL (2001)
分享论文
